Overview
- 6 inspections across 6 sites are on record.
- 15 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-10-31.
At a glance
Inspections
6
Sites
6
Observations
15
Career since
Oct 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Nordson Medical Design and Development, Inc. | 31 Oct 2023 | Human Drugs | View 483 → |
| Simcere Pharmaceutical Co., Ltd. | 17 Jan 2020 | Human Drugs | |
| Catalent Ontario Limited | 12 Apr 2019 | Human Drugs | On file |
| Evonik Corporation | 10 Aug 2018 | Human Drugs | View 483 → |
| Hercon Pharmaceuticals, LLC | 28 Apr 2017 | Human Drugs | View 483 → |
Sites inspected
Nordson Medical Design and Development, Inc.San Jose, United States1 insp.
Simcere Pharmaceutical Co., Ltd.Nanjing, China1 insp.
Catalent Ontario LimitedStrathroy, Canada1 insp.
Evonik CorporationBirmingham, United States1 insp.
Hercon Pharmaceuticals, LLCEmigsville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Christopher R Czajka1 shared
Christopher T Middendorf1 shared
Ucheabuchi C Chudi-Nwankwor1 shared
Samantha J Bradley1 shared
Cedar H Boakye1 shared
James M Mason1 shared
Nicole E Knowlton1 shared
Full investigator report
Get the verbatim findings behind Yubing Tang's 15 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site